Key takeaways
Atrovent HFA (ipratropium) and Combivent Respimat (ipratropium/albuterol) are both used to help with breathing issues, but they have different uses and forms. Atrovent HFA is an inhaled anticholiergic medication used as maintenance treatment for chronic obstructive pulmonary disease (COPD). It works by blocking acetylcholine in the lungs, which allows the muscles in your airway to relax, making it easier to breathe. Combivent Respimat, on the other hand, is an inhaler used to treat chronic obstructive pulmonary disease (COPD) and contains a combination of ipratropium and albuterol. This means combines the effects of a short-acting muscarinic antagonist (SAMA) and a short-acting beta-agonist (SABA) to relax and open airways. Both medications are brand-name only. Atrovent HFA is typically used four times a day, whereas Combivent Respimat is used up to 6 times a day for breathing issues.
